Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail

Hyuk Moon1, Hye-Lim Ju2, Sook In Chung2

  • 1Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea; Brain Korea 21 Project for Medical Science College of Medicine, Yonsei University, Seoul, South Korea.

Gastroenterology
|July 24, 2017
PubMed
Abstract

Insights

Transforming growth factor beta (TGF-β) inhibition reduces liver tumor formation and growth by targeting the Snail gene. Snail is essential for hepatic tumorigenesis, as its inhibition prevents tumor growth and its overexpression restores it.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transforming growth factor beta (TGF-β) signaling plays a dual role in tumorigenesis, suppressing early stages but promoting migration and metastasis.
  • Mutations inactivating TGF-β pathway components are common in human tumors, suggesting its tumor-suppressive functions.
  • The specific role of TGF-β signaling in liver cancer initiation and progression requires further investigation.

Purpose of the Study:

  • To investigate the effects of TGF-β inhibition on liver tumorigenesis in a mouse model.
  • To identify key downstream targets of TGF-β signaling involved in liver tumor formation.
  • To explore the therapeutic potential of targeting TGF-β signaling in hepatocellular carcinoma.

Main Methods:

  • Liver tumors were induced in C57BL/6 mice using transposons encoding oncogenes (HRASG12V) and suppressors of tumor suppressors (p53 shRNA) or other oncogenes (MYC, TAZS89A).
  • TGF-β signaling was inhibited using SMAD7 overexpression or knockdown of SMAD2, SMAD3, or SMAD4.
  • The role of Snail (SNAI1) was assessed by knockdown or ectopic expression, with analyses including gene expression, protein levels, and cell proliferation assays.

Main Results:

  • Inhibition of TGF-β signaling (via SMAD7 or SMAD2/3/4 knockdown) consistently reduced liver tumor formation and growth in multiple mouse models.
  • TGF-β signaling was found to activate Snail transcription in induced liver tumors.
  • Snail knockdown suppressed liver tumorigenesis, while its ectopic expression restored tumor formation even when TGF-β signaling was inhibited.

Conclusions:

  • TGF-β signaling is essential for the formation of liver tumors driven by activated RAS and either p53 loss or TAZ activation.
  • Snail is a critical TGF-β target gene required for hepatic tumorigenesis in these models.
  • Targeting the TGF-β/Snail axis presents a potential therapeutic strategy for hepatocellular carcinoma.